About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Detroit | 19,719 Studies Near You | Clareo Health

Clinical Trials LocationsDetroit

Clinical Trials in Detroit

Discover 19,719 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 19401-19420 of 19,719 trials

COMPLETEDPhase 32.6 miles

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293930

A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis

Astellas Pharma Inc645 participants

Hot Springs, Arkansas, United States • San Diego, California, United States • San Francisco, California, United States +29 more locations

COMPLETEDPhase 32.6 miles

The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death

NCT00568737

Adult Patients with Severe Sepsis

Eli Lilly and Company2,640 participantsStarted Nov 2002

Haedi, Buenos Aires, Argentina • Monte Grande, Buenos Aires, Argentina • Rosario - Santa Fe, Buenos Aires, Argentina +67 more locations

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

TERMINATEDPhase 213 miles

Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery Disease

NCT00137332

The purpose of this study is to learn the effects of a test drug on heart rhythms, which may become life-threatening if left untreated, and to provide data to see if the drug is well tolerated and safe.

Wyeth is now a wholly owned subsidiary of Pfizer90 participantsStarted Nov 2005

Sacramento, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +30 more locations

TERMINATEDPhase 320 miles

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

NCT00267267

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. Cholesterol levels will be measured over six weeks in subjects being treated with two different kinds of combination cholesterol medications to see how the different treatments compare to one another.

HyperlipidemiaDyslipidemia

Pfizer1,784 participantsStarted Jan 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Chandler, Arizona, United States +120 more locations

COMPLETEDPhase 336 miles

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293891

A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis.

Astellas Pharma Inc658 participants

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • San Diego, California, United States +30 more locations

TERMINATEDPhase 353 miles

Clinical Trial for Ovarian Cancer (OvaRex®)

NCT00050375

This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.

Unither Pharmaceuticals354 participantsStarted Dec 2002

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +59 more locations

COMPLETEDPhase 354 miles

Amphotericin B Suspension in Refractory Chronic Sinusitis

NCT00425620

The primary objective of the study is to evaluate the safety and efficacy of Amphotericin B suspension versus placebo in the complete resolution of key chronic sinusitis symptoms during 16 weeks of treatment in patients with refractory, postsurgical CS.

Chronic Sinusitis

Accentia Biopharmaceuticals300 participantsStarted Dec 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Gilbert, Arizona, United States +65 more locations

COMPLETEDPhase 2/382 miles

Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome

NCT00424892

The primary objective is to evaluate the long-term safety of desvenlafaxine succinate sustained-release (DVS SR) during open-label treatment in adult outpatients with fibromyalgia syndrome.

Wyeth is now a wholly owned subsidiary of Pfizer600 participants

Huntsville, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +56 more locations

TERMINATEDPhase 2/382 miles

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

NCT00301431

The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.

Wyeth is now a wholly owned subsidiary of Pfizer1,050 participantsStarted Aug 2006

Huntsville, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +56 more locations

COMPLETEDNA90 miles

Assessment of Inflammatory Mediators (AIM)

NCT00219895

Specific Aim: To determine whether neutrophils, active elastase, and cytokines measured in sputum induced using hypertonic saline are useful screening tests for determining if a particular agent with known anti-inflammatory properties is a suitable candidate for more extensive clinical trials in patients with CF. This aim will be addressed using an anti-inflammatory agent, ibuprofen, that has been shown to have clinical benefit in CF. A "no treatment" arm will be included as the control group.

Cystic Fibrosis

Ramsey, Bonnie, MD120 participantsStarted Aug 2004

Birmingham, Alabama, United States • Palo Alto, California, United States • San Diego, California, United States +13 more locations

COMPLETEDPhase 390 miles

Minocycline to Treat Amyotrophic Lateral Sclerosis

NCT00047723

The purpose of this trial is to test the safety, tolerability, and effectiveness of minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).

Amyotrophic Lateral Sclerosis

National Institute of Neurological Disorders and Stroke (NINDS)400 participantsStarted Jan 2003

Scottsdale, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +27 more locations

COMPLETEDPhase 290 miles

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

NCT00318500

The purpose of the study is to evaluate the efficacy and safety of two doses of ERB-041 (75 mg and 150 mg) relative to placebo on the relief of endometriosis-related symptoms (dysmenorrhea, pelvic pain, and deep dyspareunia) in reproductive aged women.

DysmenorrheaDyspareuniaEndometriosis+1 more

Wyeth is now a wholly owned subsidiary of Pfizer150 participantsStarted May 2006

Montgomery, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +67 more locations

COMPLETEDPhase 3103 miles

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

NCT00296387

The purpose of this study is to see if rosuvastatin compared to Atorvastatin is effective in treating ACS by decreasing the ApoB/ApoA-1 ratio and if starting statin within 24 h following the onset of the first symptoms is beneficial compared to placebo.

Acute Coronary Syndrome

AstraZeneca1,160 participantsStarted Jan 2006

Aalst, Belgium • Bonheiden, Belgium • Bouge, Belgium +99 more locations

COMPLETEDPhase 3120 miles

Study of Milnacipran for the Treatment of Fibromyalgia

NCT00098124

Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia. The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.

Forest Laboratories1,200 participantsStarted Nov 2004

Birmingham, Alabama, United States • Mobile, Alabama, United States • Montgomery, Alabama, United States +77 more locations

COMPLETEDPhase 3164 miles

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

NCT00301236

The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.

Novartis252 participantsStarted Feb 2006

Mesa, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +22 more locations

COMPLETEDPhase 1164 miles

Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis

NCT00440492

The purpose of this study is to determine if PLA-695 changes the blood concentrations of methotrexate when administered together.

Arthritis, Rheumatoid

Wyeth is now a wholly owned subsidiary of PfizerStarted Dec 2006

Los Angeles, California, United States • Palo Alto, California, United States • Lake Success, New York, United States +6 more locations

TERMINATEDPhase 1/2170 miles

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

NCT00034138

The study will compare the pharmacokinetic profile of OvaRex MAb-B43.13 ascites fluid product and OvaRex MAb-B43.13 cell culture product. Safety and immune responses following treatment with the cell culture product will be evaluated.

Ovarian Neoplasms

Unither Pharmaceuticals24 participantsStarted Mar 2002

Miami, Florida, United States • Orlando, Florida, United States • South Bend, Indiana, United States +5 more locations

COMPLETEDPhase 2/3234 miles

Gabapentin in Fibromyalgia Trial (GIFT)

NCT00057278

This study will assess the safety and effectiveness of the drug gabapentin in reducing pain associated with primary fibromyalgia.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)150 participantsStarted Mar 2003

Belmont, Massachusetts, United States • Newton, Massachusetts, United States • Cincinnati, Ohio, United States

COMPLETEDPhase 2238 miles

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

NCT00116467

The purpose of this study is to evaluate clinical and laboratory safety associated with the administration of GVAX leukemia vaccine and to determine the feasibility of generation of GVAX leukemia vaccine in subjects with acute myelogenous leukemia (AML).

Acute Myelogenous Leukemia

Cell Genesys55 participantsStarted Mar 2001

San Francisco, California, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +1 more locations

UNKNOWNPhase 2388 miles

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

NCT00383851

This is a multicenter, randomized, phase II study to evaluate the safety and efficacy of oral ATN-224 plus temozolomide in patients with advanced melanoma. Patients will be randomized (1:1) between temozolomide and ATN-224 and temozolomide followed by ATN-224. Patients assigned to the sequential treatment group will receive temozolomide until progression of disease is documented and then receive ATN-224 as a single agent until documentation of progression of disease using the last tumor assessment on temozolomide therapy as the baseline assessment.

Attenuon60 participantsStarted Sep 2006

Tucson, Arizona, United States • Encinitas, California, United States • Orange, California, United States +14 more locations

PreviousPage 971 of 986Next

in Detroit

Heart Diseasein Detroit